Characteristic
|
IVIG responders (n= 36)
|
IVIG non-responders (n= 4)
|
P
|
---|
Boys/girls, number
|
21/15
|
1/3
|
0.000
|
Age, months
|
22.4 (17.2)
|
30.5 (12.8)
|
0.000
|
Patients with CALs, number
|
7
|
2
|
0.000
|
Resistin, 102 ng/ml
|
Acute stage
|
0.35 (0.24)
|
0.64 (0.30)
|
0.032
|
|
Afebrile stage
|
0.21 (0.19) **
|
0.48 (0.35)
|
0.019
|
|
Subacute stage
|
0.12 (0.05) **▲
|
0.28 (0.19)
|
0.000
|
S100A12, 102 ng/ml
|
Acute stage
|
5.05 (3.22)
|
7.92 (2.61)
|
0.044
|
|
Afebrile stage
|
3.99 (3.49)
|
4.80 (4.26)
|
0.668
|
|
Subacute stage
|
2.35 (2.26)** ▲
|
4.98 (4.75)
|
0.047
|
sRAGE, 102 pg/ml
|
Acute stage
|
3.07 (1.98)
|
2.37 (0.96)
|
0.493
|
|
Afebrile stage
|
6.00 (2.78)**
|
3.51 (2.64)
|
0.046
|
|
Subacute stage
|
7.19 (2.88)**
|
3.65 (3.27)
|
0.026
|
- Results are mean (SD) unless stated otherwise. CALs, coronary artery lesions; **P < 0.01 compared with acute stage; ▲P < 0.05 compared with afebrile stage.